Weg met de pil. Focus is bij MSD het toverwoord
Moederbedrijf MSD splitst de activiteiten voor ‘vrouwengezondheid’ af. Wat betekent dat voor het voormalige Organon uit Oss, de uitvinder van de anticonceptiepil?
Read more
Grote opkomst bij eerste gezamenlijke Burenavond op Moleneind
OSS, 31 januari 2020 – De Burenavond die Aspen, Pivot Park en MSD donderdagavond hebben gehouden voor omwonenden is een...
Read more
Dutch meniscus prosthesis from ATRO Medical receives FDA Breakthrough Device Designation
Dutch medical innovations are rarely granted the Breakthrough Designation by the FDA. Startup ATRO Medical, with offices at Pivot Park,...
Read more
Welkom in Pivot Park waar gewerkt wordt aan nieuwe medicijnen
De ontwikkeling van nieuwe medicijnen groeit hard in Nederland. Het 6 hectare metende Pivot Park in Oss moet al bijbouwen...
Read more
Inprocess-LSP 100th investment of Mibiton
During the Dutch Life Sciences Conference 2019, held in Leiden, the Mibiton Foundation celebrated its 25-year anniversary. Mibiton has made...
Read moreArdena launches integrated drug discovery support services
This year we’re back at CPhI Worldwide in Frankfurt to highlight our drug discovery support service program. We are excited...
Read moreNew website for NTRC Precision Medicine Services
NTRC Precision Medicine Services puts its cell-based profiling offers in the spotlight on the new website www.oncolines.com. The website focuses...
Read more
Citryll welcomed as 60th tenant
Pivot Park officially welcomed Citryll as the 60th tenant. “We are very pleased to have Citryll onboard our community, and...
Read more
Ongoing expansion of Acerta Pharma’s discovery and clinical operations in Oss
Acerta Pharma is one of the most successful pharmaceutical companies at Pivot Park. The discovery team has recently doubled in...
Read more